Article info
Original research
Molecular characterisation of pancreatic ductal adenocarcinoma with NTRK fusions and review of the literature
- Correspondence to Dr Grainne M O'Kane, Wallace McCain Centre for Pancreatic Cancer, Princess Margaret Hospital, Toronto, ON M5G 2C1, Canada; Grainne.O'Kane{at}uhn.ca
Citation
Molecular characterisation of pancreatic ductal adenocarcinoma with NTRK fusions and review of the literature
Publication history
- Received July 16, 2021
- Accepted September 1, 2021
- First published September 28, 2021.
Online issue publication
October 18, 2023
Article Versions
- Previous version (17 February 2023).
- Previous version (17 February 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.